Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2025-09-02 | 1,210 | $167.71 | $202.93kSell |
Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2025-09-02 | 500 | $166.39 | $83.20kSell |
Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2025-09-02 | 1,290 | $165.69 | $213.73kSell |
Steven Leonard Chapman | CEO AND PRESIDENT | 2025-09-02 | 1,700 | $165.44 | $281.24kSell |
Steven Leonard Chapman | CEO AND PRESIDENT | 2025-09-02 | 1,472 | $166.29 | $244.77kSell |
Steven Leonard Chapman | CEO AND PRESIDENT | 2025-09-02 | 1,907 | $167.69 | $319.78kSell |
Rowan E. Chapman | Director | 2025-08-28 | 2,750 | $166.99 | $459.22kSell |
John Fesko | PRESIDENT CHIEF BUS. OFFICER | 2025-08-14 | 672 | $155.46 | $104.47kSell |
Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2025-08-14 | 8 | $155.43 | $1.24kSell |
Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2025-08-14 | 867 | $155.46 | $134.78kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Vanguard Group Inc | 9.28% | 12,676,653 | $2.18B | Institution |
Price T Rowe Associates Inc | 8.93% | 12,187,816 | $2.10B | Institution |
Blackrock Inc | 8.02% | 10,956,715 | $1.89B | Institution |
Jpmorgan Chase Co | 7.78% | 10,625,785 | $1.83B | Institution |
Claremont Creek Ventures L P | 4.29% | 5,864,630 | $1.01B | Insider |
Roelof Botha | 4.16% | 5,683,920 | $978.54M | Insider |
Sc XII Management LLC | 3.97% | 5,421,122 | $933.30M | Insider |
Matthew Rabinowitz | 3.60% | 4,914,420 | $846.07M | Insider |
Farallon Capital Management LLC | 3.53% | 4,821,809 | $830.12M | Institution |
James Healy | 3.44% | 4,697,100 | $808.65M | Insider |